How effective is Coumadin for Antithrombin Iii Deficiency? (a real world drug study)
Summary:
Overall ratings: 4/5 Long term ratings: 4/5
This is a phase IV clinical study of how effective Coumadin (warfarin sodium) is for Antithrombin iii deficiency and for what kind of people. The study is created by eHealthMe from 3 Coumadin users and is updated continuously.
What is Coumadin?
Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 133,228 Coumadin users. Check the latest studies of Coumadin.
What is Antithrombin iii deficiency?
Antithrombin iii deficiency (rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism, and repetitive intrauterine fetal death (iufd)) is found to be associated with 13 drugs and 109 conditions by eHealthMe. Check the latest studies of Antithrombin iii deficiency.
3 people are studied for taking Coumadin in Antithrombin iii deficiency
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Coumadin effectiveness for Antithrombin iii deficiency (number of people):
Overall:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 3
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 0
- high: 3
- very high: 0
Gender of people who take Coumadin for Antithrombin iii deficiency *:
- female: 33.33 %
- male: 66.67 %
Age of people who take Coumadin for Antithrombin iii deficiency *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Who find Coumadin more effective for Antithrombin Iii Deficiency?
Gender of people who take Coumadin for Antithrombin iii deficiency *:
- female: 33.33 %
- male: 66.67 %
Age of people who take Coumadin for Antithrombin iii deficiency *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Coumadin?
- You can start a phase IV clinical trial to monitor Coumadin safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Coumadin (133,228 reports)
Treatments, associated drugs and conditions:
- Antithrombin iii deficiency (305 reports)
How the study uses the data?
The study is based on warfarin sodium (the active ingredients of Coumadin) and Coumadin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Amifostine and Flagyl - 3 seconds ago
- Could Pulmicort cause Hyperkalemia? - 3 seconds ago
- Could Baraclude cause Lung Disorder? - 12 seconds ago
- Drug interactions of Ms Contin and Glycolax - 16 seconds ago
- Drug interactions of Diphenhydramine Hydrochloride and Lithium Carbonate - 37 seconds ago
- Could Fentanyl cause Nephrogenic Anaemia? - 56 seconds ago
- Could Metformin cause Bone Marrow Failure? - a minute ago
- Could Vinorelbine cause Heart Attack? - a minute ago
- Could Dexilant cause Lymph Follicular Hypertrophy? - a minute ago
- Could Camptosar cause Breathing - Slowed Or Stopped? - a minute ago